ACUTE Cardiovascular Flashcards

1
Q

Which meds are vasopressors:

A
  • Norepinephrine
    • Epinephrine
    • Phenylephrine
    • Vasopressin
    • Dopamine (at higher doses)
    • Midodrine (oral alpha-1 agonist for step-down weaning)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which meds cause tachycardia

A
  • Epinephrine
    • Dopamine
    • Dobutamine
    • Hydralazine
    • Isoproterenol
    • Nitroprusside (reflex)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which meds DO NOT cause tachycardia

A
  • Phenylephrine (may actually cause reflex bradycardia)
    • Vasopressin
    • Beta-blockers (e.g., Metoprolol)
    • Non-DHP CCBs (e.g., Diltiazem)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which meds result in increased CO

A
  • Milrinone
    • Dobutamine
    • Dopamine
    • Epinephrine
    • Digoxin
    • Norepinephrine (modestly)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which meds increase myocyte contractility

A

(Positive inotropes)
* Digoxin
* Dobutamine
* Epinephrine
* Milrinone
* Levosimendan (calcium sensitizer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which meds prolong QT intervals

A
  • Class Ia (e.g., Quinidine, Procainamide)
    • Class III (e.g., Amiodarone, Sotalol, Dofetilide)
    • Risk of Torsades de Pointes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which meds would benefit patient with cardiogenic shock

A
  • Milrinone (esp. if on beta-blocker)
    • Dobutamine
    • Norepinephrine (if hypotensive too)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which medications are indicated for primary management of acute decompensated heart failure

A
  • Milrinone
    • Loop diuretics (e.g., Furosemide)
    • Nitroglycerin (if hypertensive with pulmonary edema)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which medications are not indicated for primary management of acute decompensated heart failure

A
  • Phenylephrine (increases afterload)
    • Non-DHP CCBs (e.g., Diltiazem)
    • Nifedipine (DHP CCB)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which meds you’d recommend for patient who has asthma with an underlying arrhythmia

A
  • Avoid beta-blockers (esp. nonselective)
    • Use Non-DHP CCBs (e.g., Diltiazem or Verapamil) cautiously (unless HFrEF)
    • Digoxin can also help with rate control in Afib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which meds used to treat junctional tachycardia

A
  • Beta-blockers (if no contraindications)
    • Non-DHP CCBs: verapamil, diltiazem
    • Amiodarone (in more severe/unstable cases)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Chronic Afib treatment with decreased CO

A
  • Digoxin
    • Beta-blockers (e.g., Metoprolol)
    • Amiodarone (for rhythm control)
    • Avoid Non-DHP CCBs if HFrEF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Class III antiarrhythmic agents: potassium channel blockers

A

Amiodarone
Dofetilide : strict QT monitoring, oral only
Ibutilide: IV only, rapid cardioversion in afib/flutter
Sotalol: nonselective B-blocker + K channel blocker
* Dronedarone: like amid, rapid conversion afib/flutter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Positive Lusitropic

A

myocardial relaxation (e.g., beta-agonists ↑ lusitropy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bathmotropic

A

: excitability (threshold potential, not a common clinical term)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dromotropic

A

conduction velocity (e.g., beta-blockers ↓ it)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Chronotropic

A

heart rate (e.g., epinephrine ↑, beta-blockers ↓)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

RAAS System Summary

A
  1. ↓ perfusion → Renin release
    1. Renin → Angiotensin I → (via ACE) → Angiotensin II
    2. Angiotensin II → vasoconstriction + aldosterone release
    3. Aldosterone → Na⁺/water retention → ↑ BP
19
Q

midodrine

A

MOA: alpha agonist
Indications: orthostatic hypotension
Contraindications: supine HTN

20
Q

milrinone

A

MOA: PDE3 inhibitor> increases cardiac contractility, decreased vascular resistance
Indications: low output HF (works independently of beta receptors)
Contraindications: risk of arrhythmias, hypotension, HF exacerbation, renal failure

21
Q

digoxin

A

MOA: Na⁺/K⁺ ATPase inhibitor> less Na exchange = more Ca in cells = increased contractility
Indications: afib, HFrEF
Contraindications: renal dosing, risk of toxicity

22
Q

carvedilol

A

MOA: β/α-blocker
Indications: HFrEF
Contraindications: asthma, bradycardia

23
Q

nitroglycerin

A

MOA: NO donor> balanced arterial and venous dilation
Indications: angina, pulmonary edema, preload reduction
Contraindications: headache, tolerance

24
Q

ARBS

A

MOA: block AT1 receptors> prevent vasoconstriction and aldosterone release
Indications: HF, HTN
Contraindications: hyperkalemia, pregnancy

25
nitroprusside
MOA: NO donor Indications: rapid BP control Contraindications:cyanide toxicity,
26
Calcium sensitizer: levosimendan
not FDA approved, less arrhythmia risk
27
BB and acute coronary syndrome
MOA: decrease HR, decrease O2 demand Indications: fib, post MI, HFrEF Contraindications: avoid in acute decompensated heart failure and asthma
28
digibind
MOA: binds to dig and excreted in urine Indications: toxicity Contraindications: hypokalemia
29
dopamine
MOA: improve SV and CO, increase arterial BP Indications: dose dependent effects Contraindications: arrhythmia risk
30
Contraindications of non DHP calcium channel blocker
* HFrEF * Bradycardia * 2nd/3rd degree AV block
31
Which med to use for weaning stable patient from IV pressers
Midodrine PO TID during daytime (ideal for step-down from norepinephrine)
32
Appropriate vasodilation for initial management of HTN with pulmonary edema
Nitroglycerin (venodilator → ↓ preload)
33
Signs of dig toxicity
*N/V, visual disturbances (yellow-green halos), confusion, arrhythmias, bradycardia
34
Indications of use for class 1B antiarrhythmics
* Ventricular arrhythmias, especially post-MI * Examples: Lidocaine, Mexiletine
35
Which antiarrhythmic puts you at the greatest risk of torsades
* Class Ia (Quinidine, Procainamide) * Class III (Dofetilide, Sotalol)
36
Which receptors are responsible for increasing systemic blood pressure while on vasopressin
V1 receptor: vasoconstriction → ↑ systemic BP
37
Contraindications for ACE and ARBs
* Pregnancy * Hyperkalemia * Bilateral renal artery stenosis * Severe renal dysfunction
38
SE of chronic amiodarone therapy
* Pulmonary fibrosis * Hepatotoxicity * Thyroid dysfunction * Blue-gray skin * Corneal deposits * Bradycardia
39
Which vasodilator puts you at risk cyanide toxicity
Nitroprusside
40
BEERs criteria and why avoid hydralazine in elderly
Risk of orthostatic hypotension * Unpredictable half-life * Reflex tachycardia * Risk of falls
41
Whats special about sotalol
* Beta-blocker + Class III (K⁺ blocker) * Dual antiarrhythmic effect * QT prolongation risk
42
Contraindications for 1C agents
* Structural heart disease * Post-MI * Heart failure
43
Diuretic classes and their side effects
Loop, SE ototoxicity, decrease K &Ca Thiazide: HCTZ, SE high Ca, high glucose, high uric acid K sparing, spironolactone, increased K, gynecomastia
44
Best drug for hypertension emergency in pregnancy is
Labetalol (IV), Hydralazine (also used but not preferred due to unpredictable response)